Gerosuppressant metformin cannot distinguish between mTOR-driven program (which drives growth, fitness and the onset of reproduction early in life) and quasi-program (which causes menopauses, diseases such as cancer and aging later in life, when the mTOR-driven program becomes aimless) [151-153]. Here, MTOR is linked to cancer.